We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RTN
76
DELISTED
Raytheon Company
RTN
| $37.8M | 0.35% |
+303,584
| New | +$36.5M |
|
|
SIVB
77
DELISTED
SVB Financial Group
SIVB
| $36.7M | 0.34% |
308,990
+57,581
| +23% | +$7.14M |
|
78
Electronic Arts
EA
$52.9B
| $36.7M | 0.34% |
533,368
-104,945
| -16% | -$7.36M |
|
79
Travelers Companies
TRV
$79.8B
| $36.5M | 0.34% |
323,277
-213,233
| -40% | -$23.7M |
|
|
QVCGA
80
DELISTED
QVC Group Inc Series A
QVCGA
| $36.3M | 0.34% |
27,340
+27,024
| +8,552% | +$35.4M |
|
|
P
81
DELISTED
Pandora Media Inc
P
| $36.3M | 0.34% |
2,703,772
+1,866,814
| +223% | +$27.8M |
|
82
Constellation Brands
STZ
$22.3B
| $36.2M | 0.34% |
254,333
+250,840
| +7,181% | +$34.5M |
|
83
DaVita
DVA
$12.1B
| $36.1M | 0.34% |
518,068
+4,044
| +0.8% | +$296K |
|
|
OVTI
84
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $35.6M | 0.33% |
1,227,865
+1,107,407
| +919% | +$31.8M |
|
85
Teleflex
TFX
$6.06B
| $35.5M | 0.33% |
270,076
+95,815
| +55% | +$12.5M |
|
86
Marriott International
MAR
$94.2B
| $35.4M | 0.33% |
527,381
+406,027
| +335% | +$29.4M |
|
|
LNKD
87
DELISTED
LinkedIn Corporation
LNKD
| $33.2M | 0.31% |
147,574
+142,264
| +2,679% | +$32.3M |
|
88
Universal Health Services
UHS
$10.4B
| $33.1M | 0.31% |
277,096
+52,038
| +23% | +$6.36M |
|
89
Starbucks
SBUX
$121B
| $32.8M | 0.31% |
546,900
-73,944
| -12% | -$4.5M |
|
|
DFS
90
DELISTED
Discover Financial Services
DFS
| $32.7M | 0.31% |
610,531
+339,352
| +125% | +$18.8M |
|
|
POT
91
DELISTED
Potash Corp Of Saskatchewan
POT
| $32.6M | 0.31% |
1,905,657
+1,846,582
| +3,126% | +$36.7M |
|
92
Huntington Ingalls Industries
HII
$12.5B
| $31.5M | 0.3% |
248,574
+181,361
| +270% | +$22.2M |
|
|
SYNH
93
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $31.5M | 0.3% |
649,846
+403,754
| +164% | +$18M |
|
|
DD
94
DELISTED
Du Pont De Nemours E I
DD
| $31.1M | 0.29% |
467,614
+399,100
| +583% | +$25.3M |
|
95
Cigna
CI
$71.5B
| $30.8M | 0.29% |
210,298
+171,453
| +441% | +$23.6M |
|
96
Humana
HUM
$43.7B
| $30.5M | 0.29% |
171,008
+139,942
| +450% | +$24.6M |
|
97
Vertex Pharmaceuticals
VRTX
$123B
| $30.4M | 0.29% |
241,824
+148,314
| +159% | +$17.9M |
|
98
C.H. Robinson
CHRW
$17.9B
| $29.9M | 0.28% |
+482,509
| New | +$32.5M |
|
99
Abbott
ABT
$183B
| $29.7M | 0.28% |
660,627
-1,147,309
| -63% | -$50.7M |
|
|
CVC
100
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $27.9M | 0.26% |
874,635
+717,614
| +457% | +$22.7M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.